纳米向输送系统:对于治疗肠道炎症而言,素封装是一种有前途的策略
Hao Zhong1, Xin Luo1, Abdullah1
1College of Food Science and Technology, Zhejiang University of Technology, Hangzhou, China.
Critical reviews in food science and nutrition
|February 7, 2025
概括
安托氨酸在炎症性肠病中表现有前途,但面临着交付挑战. 纳米载体增强了对肠道炎症治疗的安托西亚宁生物可用性和有效性.
科学领域:
- 自然产品 化学 化学
- 药理学 药理学是指药理学的学科.
- 胃肠病学 胃肠病学
背景情况:
- 植物衍生性黄酸具有抗炎和抗氧化特性,对炎症性肠病 (IBD) 有好处.
- 诸如溶解性差,生物可用性低和不稳定性等局限性阻碍了它们在IBD中的治疗应用.
- 炎症性肠病,包括克罗恩氏病和性结肠炎,代表着一个重要的未满足的医疗需求.
研究的目的:
- 审查纳米载体系统,以改善在治疗IBD时的安托西亚宁的输送.
- 讨论通过纳米载体增强安东素有效性和生物可用性的策略.
- 探索抗肠道炎症的安托素和纳米载体的机制.
主要方法:
- 关于纳米载体系统 (脂质体,聚合体,外体体等) 的文献综述. 用于安东素的输送.
- 分析高级策略:表面功能化,响应释放,磁性定向,自组装.
- 检查安东的生物活性 (抗氧化,抗炎,肠道微生物群调节,诱导亡).
主要成果:
- 纳米载体有效地克服了安东素的低溶解性,透性和生物可用性问题.
- 表面功能化和响应式释放策略改善了向性交付和治疗结果.
- 载有安东的纳米载体在肠道炎症的临床前模型中显示出显著的潜力.
结论:
- 纳米载体代表了一种有前途的策略,用于口服输送安托西亚宁来治疗炎症性肠道疾病.
- 对先进的纳米载体设计和功能性食品的进一步研究可以优化IBD的安托西亚宁疗法.
- 通过纳米载体进行向的输送和增强的生物可用性是释放安托西亚宁在IBD中的全部治疗潜力的关键.
更多相关视频
07:05Fluorescence-mediated Tomography for the Detection and Quantification of Macrophage-related Murine Intestinal Inflammation
Published on: December 15, 2017
8.2K
06:26Synthesis of Stimuli-responsive Nanogels using Aqueous One-step Crosslinking and Co-nanopolymerization
Published on: January 24, 2025
910
相关概念视频
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...
Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
Oral Drug Delivery Systems: Delayed-Release Systems
Delayed-release drug delivery systems are specialized pharmaceutical formulations designed to postpone the release of active compounds until the drug reaches a specific region of the gastrointestinal (GI) tract, typically the intestine. These systems are essential for drugs that may cause gastric irritation, are unstable in acidic environments, or need to exert therapeutic effects locally in the intestinal or colonic regions.The core feature of delayed-release systems is the use of enteric...
